Invesco’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
|
|||||
|
2025
Q1 | $619K | Buy |
|
|||||
|
2024
Q4 | $479K | Buy |
|
|||||
|
2024
Q3 | $443K | Buy |
|
|||||
|
2024
Q2 | $348K | Buy |
|
|||||
|
2024
Q1 | $910K | Buy |
|
|||||
|
2023
Q4 | $1.98M | Sell |
|
|||||
|
2023
Q3 | $9.24M | Sell |
|
|||||
|
2023
Q2 | $15.7M | Buy |
|
|||||
|
2023
Q1 | $2.17M | Sell |
|
|||||
|
2022
Q4 | $2.58M | Buy |
|
|||||
|
2022
Q3 | $653K | Sell |
|
|||||
|
2022
Q2 | $513K | Buy |
|
|||||
|
2022
Q1 | $1.01M | Sell |
|
|||||
|
2021
Q4 | $65.4M | Buy |
|
|||||
|
2021
Q3 | $2.36M | Buy |
|
|||||
|
2021
Q2 | $2.84M | Sell |
|
|||||
|
2021
Q1 | $39.4M | Sell |
|
|||||
|
2020
Q4 | $44M | Sell |
|
|||||
|
2020
Q3 | $17.6M | Buy |
|
|||||
|
2020
Q2 | $165K | Sell |
|
|||||
|
2020
Q1 | $160K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $139K | Buy |
|
|||||
|
2018
Q4 | $133K | Sell |
|
|||||
|
2018
Q3 | $121K | Buy |
|
|||||
|
2018
Q2 | $64K | Sell |
|
|||||
|
2018
Q1 | $120K | Sell |
|
|||||
|
2017
Q4 | $11M | Sell |
|
|||||
|
2017
Q3 | $27.2M | Sell |
|
|||||
|
2017
Q2 | $18.5M | Sell |
|
|||||
|
2017
Q1 | $26.9M | Sell |
|
|||||
|
2016
Q4 | $20.2M | Buy |
|
|||||
|
2016
Q3 | $108K | Sell |
|
|||||
|
2016
Q2 | $85K | Sell |
|
|||||
|
2016
Q1 | $2.16M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $6K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $1.47M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $2.2M | Buy |
|
|||||
|
2014
Q1 | $805K | Sell |
|
|||||
|
2013
Q4 | $3.41M | Buy |
|
|||||
|
2013
Q3 | $835K | Sell |
|
|||||
|
2013
Q2 | $635K | Buy |
|